<DOC>
	<DOCNO>NCT01192568</DOCNO>
	<brief_summary>This study evaluate safety efficacy Oxybutynin Chloride 10 % Topical Gel child 3 less 17 year old , overactive bladder due neurogenic condition . Children treat 0.75 g gel/day two week . Patients return clinic potential dose titration . At time dose may adjust 1g/day , 0.5g/day , remain 0.75g gel/day depend individual response tolerability . The total treatment time 14 week total time study 16 week .</brief_summary>
	<brief_title>Safety Efficacy Evaluation Oxybutynin Topical Gel In Children With Neurogenic Bladder</brief_title>
	<detailed_description>This study use two-part , multicenter , dose-titration study pediatric patient detrusor overactivity associate neurological condition</detailed_description>
	<mesh_term>Urinary Bladder , Neurogenic</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>3 year &lt; 17 year Neurogenic bladder Neurological condition CIC Have anatomical bladder abnormality Sensitivity anticholinergic Bladder augmentation</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>